Clinical Features and Risk of Relapse in Children and Adults with Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease

Overview of attention for article published in Annals of Neurology, October 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (93rd percentile)
High Attention Score compared to outputs of the same age and source (81st percentile)

Mentioned by

news: 1 news outlet
blogs: 1 blog
twitter: 19 X users

patent: 1 patent
guideline: 2 clinical guideline sources

Readers on

mendeley: 150 Mendeley

So far, Altmetric has seen 2 Guidelines that reference this research output.

French guidelines for the diagnosis and management of MOG antibody-associated disease

Clinical guideline published by MIRCEM on 09 Jun 2025

MIRCEM is the National Referral Center for Neuro-Inflammatory Diseases, dedicated to collecting data on various inflammatory neurological conditions. It aims to educate the public and healthcare professionals about these diseases and propose available therapies, ensuring comprehensive support for patients and their families.

Clinical practice guidelines for myelin oligodendrocyte glycoprotein antibody-associated disease in children

Clinical guideline published by Chinese Medical Association (CMA) on 02 Nov 2023

The Chinese Medical Association (CMA) is a prominent non-profit organization established in 1915, uniting around 700,000 medical professionals across 89 specialty societies. It fosters medical science development, facilitates academic exchanges, and publishes numerous medical journals and educational resources.

This page shows the most recent posts that mention this research output. Click here to find out how to access more activity.